About 4 300 reports

Pakistan Pharmaceuticals and Healthcare Report Q3 2015

116 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Medicine sales in Pakistan will continue to grow significantly from a low base. Underpinningthis trajectory includes a reform in the country's pricing environment that will see scope for an increase inpharmaceutical prices. This will in turn encourage more investment...

985 1 300 818
May 2015

Poland Pharmaceuticals and Healthcare Report Q3 2015

113 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The National Health Fund and the Agency for Health Technology Assessment will continue toimpede the reimbursement of innovative drugs in Poland over the short term, given their current focus onbudgetary restraint. Over the longer term, we expect these budgetary restrictions...

985 1 300 818
May 2015

Hungary Pharmaceuticals and Healthcare Report Q3 2015

109 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Hungary's attractiveness to multinational drugmakers will be impeded by onerous regulatoryburden, pricing pressures and punitive taxes on pharmaceutical companies. Combined, these factors willimpede growth in pharmaceutical sales over the short-term. Consumer...

985 1 300 818
May 2015

Japan Pharmaceuticals and Healthcare Report Q3 2015

153 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The Japanese pharmaceutical market will become increasingly challenging for multinationaldrugmakers. This comes as the use of generic drugs has begun to gain momentum, creating a morecompetitive environment for innovative medicines. In addition, top line growth...

985 1 300 818
May 2015

Tanzania Pharmaceuticals and Healthcare Report Q3 2015

84 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The introduction of compulsory health insurance in Tanzania will increase uptake of thescheme among some sectors of the population. Despite the impressive employment rate, contributions fromthose employed in the informal and agriculture sectors will be less likely,...

985 1 300 818
May 2015

Hong Kong Pharmaceuticals and Healthcare Report Q3 2015

113 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Financial constrains coupled with the lack of healthcare facilities and medical professional inthe public sector meant that the private healthcare sector will play an increasingly important role in HongKong. This shift also means that patients will increasingly have...

985 1 300 818
May 2015

Austria Pharmaceuticals and Healthcare Report Q3 2015

74 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The Austrian pharmaceutical and healthcare sectors are well developed and stable, offeringsome of the most attractive opportunities in the region. Nevertheless, our pharmaceutical and healthcareexpenditure growth expectations remain resiliently subdued over the next...

985 1 300 818
May 2015

Colombia Pharmaceuticals and Healthcare Report Q3 2015

118 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The government's push for improvement to the Colombian healthcare sector, combined with thecountry's growing burden of chronic conditions and reliance on imported drugs will keep the healthcareand pharmaceutical markets on positive trajectories. However, the country's...

985 1 300 818
May 2015

Global Prostate Cancer Therapeutics Market to 2020

76 pages • By Igate Research

Prostate Cancer remains a top priority for health systems around the world as incidence level rises, fueled by growing and aging populations. The main drivers for the prostate cancer market are the increase in the global aging population, innovation in drugs and developments in genomics and proteomics. The prostate cancer market faces some...

800 1 000 640
May 2015

Slovenia Pharmaceuticals and Healthcare Report Q3 2015

95 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Positive economic developments in the eurozone and increasing competitiveness due to eurodepreciation should boost demand for Slovenian pharmaceutical exports. It is also likely that economicpickup in Slovenia will push demand for pharmaceutical imports. The Slovenian pharmaceutical...

985 1 300 818
May 2015

Central America Pharmaceuticals and Healthcare Report Q3 2015

58 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Favourable tax incentives, continued demand for both generic and patented medicines, andregional anti-counterfiet measures solidify Central America's revenue generating opportunities formultinational pharmaceutical companies in coming years. Despite political instability...

985 1 300 818
May 2015

Thailand Pharmaceuticals and Healthcare Report Q3 2015

117 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Competitively priced medical services, government support of the healthcare sector andThailand's position as a popular holiday destination will continue to boost the growth of the country'smedical tourism industry. This will provide significant revenue earning opportunities...

985 1 300 818
May 2015

Netherlands Pharmaceuticals and Healthcare Report Q3 2015

113 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The healthcare market in the Netherlands will continue to offer considerable commercialopportunities. As a part of the Health Insurance Act, implemented in 2006, private insurance for curativecare and supplemental benefits is mandatory for the entire population. However,...

985 1 300 818
May 2015

Cote d%Ivoire Pharmaceuticals and Healthcare Report Q3 2015

67 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Implementation of Côte d'Ivoire's universal healthcare scheme will drive demand forprescription medicines, with generic drugmakers the likely beneficiaries. The government will increase itsshare of the total healthcare market over the long term. More hospitals and clinics...

985 1 300 818
May 2015

South Korea Pharmaceuticals and Healthcare Report Q3 2015

145 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The South Korean government will continue to enforce price pressures on pharmaceuticals as ameans to contain the escalating healthcare costs brought on by the country's ageing population. This isparticularly as other avenues - including shifting the healthcare cost burden...

985 1 300 818
May 2015

Argentina Pharmaceuticals and Healthcare Report Q3 2015

137 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Argentina's pharmaceuticals and healthcare sector is expected to experience improved growthrates through the next decade, standing slightly behind growth patterns in the other large markets in LatinAmerica. Combined with expected improvements in the Argentinean business environment...

985 1 300 818
May 2015

2015 Market Research Report on Global and China Clotrimazole Industry

136 pages • By QY Research Group

The Global Clotrimazole Industry Report 2015 is a professional and in-depth study on the current state of the Clotrimazole industry.The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Clotrimazole market analysis is provided for the international...

2 240 2 800 1 792
May 2015

2015 Market Research Report on Global and China Dihydrocodeine Industry

135 pages • By QY Research Group

The Global Dihydrocodeine Industry Report 2015 is a professional and in-depth study on the current state of the Dihydrocodeine industry.The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Dihydrocodeine market analysis is provided for the international...

2 240 2 800 1 792
May 2015

Asia Hair Loss & growth Treatments and Products Industry Report 2015

201 pages • By QY Research Group

Asia Hair Loss & growth Treatments and Products Industry Report 2015 is a professional and in-depth study on the current state of the Hair Loss&growth Treatments and Products industry.The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Hair Loss&growth...

2 080 2 600 1 664
May 2015

Parathyroid Hormone Receptor Agonist -Pipeline Insights, 2015

By Delve Insight

SummaryDelveInsight’s, Parathyroid Hormone Receptor Agonist- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Parathyroid Hormone Receptor Agonist. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing...

1 000 1 250 800
May 2015

Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Agonists -Pipeline Insights, 2015

By Delve Insight

SummaryDelveInsight’s, Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Agonists. The main objective of this report to track competitor pipeline...

1 000 1 250 800
May 2015

Chemotherapy Induced Anemia-Pipeline Insights, 2015

60 pages • By Delve Insight

SummaryDelveInsight’s, Chemotherapy Induced Anemia- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Chemotherapy Induced Anemia. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing...

1 000 1 250 800
May 2015

Hormone Agonists -Pipeline Insights, 2015

By Delve Insight

SummaryDelveInsight’s, Hormone Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Hormone Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The...

1 000 1 250 800
May 2015

Melanin-Concentrating Hormone Receptor 1(MCHR1) Antagonists -Pipeline Insights, 2015

By Delve Insight

SummaryDelveInsight’s, Melanin-Concentrating Hormone Receptor 1(MCHR1) Antagonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Melanin-Concentrating Hormone Receptor 1(MCHR1) Antagonists. The main objective of this report to track competitor pipeline molecules, related research...

1 000 1 250 800
May 2015

Chemotherapy Induced Peripheral Neuropathy-Pipeline Insights, 2015

60 pages • By Delve Insight

SummaryDelveInsight’s, Chemotherapy Induced Peripheral Neuropathy- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Chemotherapy Induced Peripheral Neuropathy. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations,...

1 000 1 250 800
May 2015

Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonists -Pipeline Insights, 2015

By Delve Insight

SummaryDelveInsight’s, Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonists. The main objective of this report to track competitor pipeline...

1 000 1 250 800
May 2015

Pharmaceuticals Manufacturers Global - Industry Report

200 pages • By Plimsoll Publishing Ltd UK

Plimsoll’s PHARMACEUTICALS MANUFACTURERS (Global) analysis is the most definitive and accurate study of the PHARMACEUTICALS MANUFACTURERS (Global) sector in 2013.The report is split into two sections and uses both a written and graphical analysis – analysing the 200 largest PHARMACEUTICALS MANUFACTURERS (Global) companies. The...

1 150 1 668 1 035
Apr 2015

Pharmaceutical Wholesalers Nordic - Industry Report

300 pages • By Plimsoll Publishing Ltd UK

Plimsoll’s PHARMACEUTICAL WHOLESALERS (Nordic) analysis is the most definitive and accurate study of the PHARMACEUTICAL WHOLESALERS (Nordic) sector in 2013.The report is split into two sections and uses both a written and graphical analysis – analysing the 300 largest PHARMACEUTICAL WHOLESALERS (Nordic) companies. The PHARMACEUTICAL...

799 1 159 719
Apr 2015

Medicinal & Botanical Pharmaceutical Manufacturers European - Industry Report

200 pages • By Plimsoll Publishing Ltd UK

Plimsoll’s MEDICINAL & BOTANICAL PHARMACEUTICAL MANUFACTURERS (European) analysis is the most definitive and accurate study of the MEDICINAL & BOTANICAL PHARMACEUTICAL MANUFACTURERS (European) sector in 2013.The report is split into two sections and uses both a written and graphical analysis – analysing the 200 largest MEDICINAL &...

980 1 421 882
Apr 2015

Pharmaceutical Manufacturers Nordic - Industry Report

100 pages • By Plimsoll Publishing Ltd UK

Plimsoll’s PHARMACEUTICAL MANUFACTURERS (Nordic) analysis is the most definitive and accurate study of the PHARMACEUTICAL MANUFACTURERS (Nordic) sector in 2013.The report is split into two sections and uses both a written and graphical analysis – analysing the 100 largest PHARMACEUTICAL MANUFACTURERS (Nordic) companies. The...

799 1 159 719
Apr 2015